Abstract

Key Clinical MessageThe differential diagnosis of retroperitoneal mass includes liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma, neurofibroma, stromal tumor, teratoma, and lymphoma. Leiomyosarcoma is rare with poorer prognosis than other soft tissue sarcomas. Soft tissue sarcoma of retroperitoneal origin often remains asymptomatic until tumor enlargement, leading to diagnosis at advanced stages.

Highlights

  • Key Clinical MessageThe differential diagnosis of retroperitoneal mass includes liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma, neurofibroma, stromal tumor, teratoma, and lymphoma

  • Multiple lung tumors were detected at a routine medical checkup at the office on a chest X-ray in a 46-year-old woman

  • A diagnosis of leiomyosarcoma was given based on a liver biopsy showing atypical spindle cells, which were positive for smooth muscle actin (SMA) and negative for KIT, CD34, and S-100 immunohistochemically (Fig. 3)

Read more

Summary

Key Clinical Message

The differential diagnosis of retroperitoneal mass includes liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma, neurofibroma, stromal tumor, teratoma, and lymphoma. Leiomyosarcoma is rare with poorer prognosis than other soft tissue sarcomas. Soft tissue sarcoma of retroperitoneal origin often remains asymptomatic until tumor enlargement, leading to diagnosis at advanced stages. Multiple lung tumors were detected at a routine medical checkup at the office on a chest X-ray in a 46-year-old woman. CT scanning identified a 150-mm solid tumor with irregular density and some areas of weak enhancement in the left retroperitoneum, and multiple liver/lung/bone metastases (Figs 1 and 2). A diagnosis of leiomyosarcoma was given based on a liver biopsy showing atypical spindle cells, which were positive for smooth muscle actin (SMA) and negative for KIT, CD34, and S-100 immunohistochemically (Fig. 3). Leiomyosarcoma is a rare tumor with poor prognosis.

Asymptomatic giant retroperitoneal leiomyosarcoma
Conflict of Interest

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.